Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Preimplantation genetic diagnosis and the welfare of the healthy selected child

20 May 2013

By Dr Mair Crouch

Geneticist and academic lawyer

Appeared in BioNews 705

Preimplantation genetic diagnosis (PGD) is a technique that allows couples from families with a history of certain inheritable diseases to try and reduce their risk of having a child affected by the condition.

The regulation of PGD rests with the Human Fertilisation and Embryology Authority (HFEA). The HFEA has recently revised its committee structure and consideration to licence genetic conditions for PGD has been delegated to the Statutory Approvals Committee (SAC) who will have a revised decision tree and explanatory note (1).

For each application, SAC needs to be satisfied that the condition meets the statutory requirements (2). Many conditions have already been licensed by the authority but the requests will continue and, to paraphrase the Genetic Alliance UK in its response to the public consultation on the future of fertility regulation, 'we do not believe that regulation of PGD will become easier as the technology 'matures', at least not in the medium term future' (3).

The availability of the technique brings great relief to many families who hope to avoid the birth of a child with a devastating disease. However, PGD has also been licensed for use in late-onset conditions, which means that in some cases, the resulting healthy child will see a parent decline in health during its formative years. Limited research in Scotland among young people living in families with Huntington's disease found that 'while some young people cope successfully, others experience emotional, psychological, and behavioural problems and may be at risk of emotional and/or physical harm' (4).

Huntington's disease is on the list of licensed conditions along with other conditions such as early-onset Alzheimer's and frontotemporal dementia (Pick's) that are expressed in adult life. The relevant websites describe in some detail the effect of the condition on the life of the person carrying the mutation.

So what of the welfare of children born into such families? The responsibility for considering the welfare of the child rests with the clinic offering treatment under section 13(5) of the Human Fertilisation and Embryology Act 1990 (as amended) (5). The clinic needs to consider the availability of supportive parenting and it should refuse treatment if it concludes that any child who may be born or any existing child of the family is likely to be at risk of significant harm or neglect (6). Some clinics address this issue by including the concern within the Patient Information Sheet for the specific condition (7).

As a recent paper in Human Reproduction Update suggests, 'It is important to do empirical research on the psychosocial risk for children growing up with an affected or at-risk parent. This may help to more adequately answer the question as to whether specific high-risk and protective factors for the welfare of the child can be identified, and may contribute to the development of evidence-based, more differentiated, guidelines' (8).

Whilst this issue has been considered in the past (9), it might be an opportune moment to revisit the debate around the effect of some of these conditions on the wellbeing of a healthy child born into families requesting PGD.

SOURCES & REFERENCES
HFEA | 01 May 2013
 
Schedule 2 Human Fertilisation and Embryology Act 2008 | 
 
3) Response 75
Genetic Alliance UK | 
 
4) Young people’s experiences of growing up in a family affected by Huntington’s Disease. K Forrest Keenan, Z Miedzybrodzka, E Van Teijlingen, L McKee, SA Simpson.
Clinical Genetics Volume 71, Issue 2, pages 120–129, February 2007 | 
 
HFEAct 1990 (as amended) section 13(5) | 
 
Human Fertilisation and Embryology Authority | 
 
Guy's and St Thomas' Assisted Conception Unit | 
 
Human Reproduction Update | 02/2013
 
Human Reproduction (2003) 18 (3): 649-651 | 
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

03 August 2015 - by Dr Victoria Burchell 
A genome-wide study of over 4000 people with Huntington's disease has identified the location several new gene variants that influence the onset of disease symptoms...
06 July 2015 - by Kirsty Oswald 
In a national referendum, a majority of Swiss voters have supported allowing preimplantation genetic diagnosis to screen for genetic diseases...
16 February 2015 - by Nina Chohan 
Scientists have shown for the first time that whole-genome sequencing (WGS) in IVF embryos can detect 'de novo' mutations...
28 April 2014 - by Amy Reed 
In two poignant interviews for the One to One series on BBC Radio 4, Jane Hill first meets mother of three, Caroline Harding. Caroline has not one, but two children with the genetic disorder, hypohidrotic ectodermal dysplasia (HED)....
14 October 2013 - by Dr James Heather 
We had almost made it through the speakers when it happened, just before the break. It was the last speaker who did it. It was Dr Joyce Harper who said what I'd been waiting for, and dropped the Gattaca bomb...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation